U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07140757) titled 'Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers' on Aug. 22.
Brief Summary: To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.
Study Start Date: Feb. 04, 2026
Study Type: OBSERVATIONAL
Condition:
Low Risk
Papillary Thyroid Cancer
Radiofrequency Ablation
Intervention:
OTHER: Questionnaire
This questionnaire includes twenty-four questions covering patients complaints ranging from 0 to 4. Patients will be asked about the p...